KRT40 Antibody

What is KRT40 and why is it targeted in research?

KRT40 is a type I keratin protein encoded by the KRT40 gene in humans, with an amino acid length of 431 and an expected molecular mass of 48.1 kDa. It may also be known as CK-40, K40, KA36, keratin type I cytoskeletal 40, and cytokeratin-40 . This protein is of research interest because it plays a role in late hair differentiation and contributes to the intermediate filament structure in epithelial cells, particularly in hair follicles. KRT40 is part of the cytoskeletal network that, along with actin microfilaments and microtubules, provides structural support to epithelial cells .

What are the common applications of KRT40 antibodies in research?

KRT40 antibodies are utilized in multiple experimental techniques including:

These applications allow researchers to detect and quantify KRT40 expression in various tissues and experimental systems .

What species reactivity is available for KRT40 antibodies?

Current research antibodies for KRT40 demonstrate reactivity with:

• Human (primary target)

• Mouse

• Rat

• Various other species including canine, porcine, and monkey

Cross-reactivity varies between antibody products, making species validation critical for research applications . When studying non-human models, researchers should select antibodies that have been specifically validated for their species of interest.

How do I optimize immunohistochemistry protocols for KRT40 detection in hair follicle samples?

Optimizing IHC for KRT40 in hair follicle samples requires careful attention to several parameters:

• Sample preparation: For hair follicle samples, optimal fixation in 4% paraformaldehyde for 24 hours is recommended, followed by careful processing to maintain tissue architecture.

• Antigen retrieval: Heat-induced epitope retrieval using citrate buffer (pH 6.0) at 95-100°C for 20 minutes typically yields best results for KRT40 detection.

• Antibody selection: Monoclonal antibodies like AE13 clone have been extensively validated for hair cortex cytokeratin/K40 detection in hair follicles .

• Titration: Begin with a 1:25 - 1:100 dilution range and optimize based on signal-to-noise ratio .

• Control samples: Always include positive controls (human hair follicle sections) and negative controls (primary antibody omission and isotype controls).

• Detection system: Polymer-based detection systems typically provide superior sensitivity compared to biotin-avidin systems for hair follicle research.

• Counterstaining: Light hematoxylin counterstaining preserves visualization of KRT40 signals in hair follicle structures.

This methodology has been validated in multiple publications focusing on hair biology and development .

What are the potential cross-reactivity issues with KRT40 antibodies and how can they be addressed?

Cross-reactivity remains a significant challenge in keratin research due to sequence homology between family members. For KRT40 specifically:

Common cross-reactivity issues:

• KRT40 antibodies may cross-react with other type I keratins, particularly KRT35, a notable paralog .

• Antibodies raised against full-length KRT40 show higher cross-reactivity than those targeting unique epitopes.

• Non-specific binding to hair and epithelial structures can complicate interpretation.

Methodological solutions:

• Epitope selection: Choose antibodies targeting the middle region or unique domains of KRT40 to minimize cross-reactivity .

• Validation controls: Include knockout/knockdown samples when available or tissues known to lack KRT40 expression.

• Multiplexed detection: Use co-staining with other keratin markers to establish specificity through co-localization patterns.

• Antibody validation: Confirm specificity using multiple techniques (WB, IHC, IF) and compare results across different antibody clones.

• Pre-absorption controls: Pre-incubate antibodies with recombinant KRT40 protein to demonstrate specificity of staining.

Recent comparative studies have shown that monoclonal antibodies provide higher specificity for KRT40 compared to polyclonal alternatives, particularly the AE13 clone which has been referenced in multiple publications .

What are the appropriate sample preparation methods for KRT40 detection in different experimental contexts?

Sample preparation varies significantly by experimental application:

For Western Blot:

• Extract total protein using RIPA buffer supplemented with protease inhibitors

• Maintain samples at 4°C throughout preparation to prevent keratin degradation

• Include reducing agents (β-mercaptoethanol) in sample buffer

• Heat samples at 95°C for 5 minutes to denature keratin filaments

• Load 25-50 μg of total protein per lane

For ELISA:

• For serum/plasma: Collect samples in EDTA or heparin tubes, centrifuge at 1000 × g (2-8°C) for 15 minutes within 30 minutes of collection

• For tissue homogenates: Rinse tissues in pre-cooled PBS, homogenize in fresh lysis buffer, sonicate until clear, and centrifuge at 10000 × g for 5 minutes

• For cell lysates: Wash adherent cells with PBS, detach with trypsin, centrifuge at 1000 × g for 5 minutes, wash 3 times in PBS, resuspend in fresh lysis buffer at 10⁷ cells/mL, sonicate if necessary

For Immunohistochemistry:

• Fix tissue samples in 10% neutral buffered formalin for 24-48 hours

• Process and embed in paraffin following standard protocols

• Section at 4-5 μm thickness

• Perform antigen retrieval (typically heat-induced with citrate buffer at pH 6.0)

• Block endogenous peroxidases and non-specific binding sites

Each of these preparation methods has been optimized through empirical testing to maintain KRT40 integrity while maximizing detection sensitivity.

How can I troubleshoot weak or absent KRT40 immunostaining in hair follicle research?

When facing weak or absent KRT40 immunostaining in hair follicle samples, consider this systematic troubleshooting approach:

Technical factors:

• Fixation issues: Overfixation can mask epitopes. Try reducing fixation time or switching to a milder fixative like 4% PFA.

• Antigen retrieval optimization: Test multiple retrieval methods (citrate pH 6.0, EDTA pH 8.0, enzymatic) and durations.

• Antibody concentration: Increase primary antibody concentration incrementally (e.g., from 1:100 to 1:50, 1:25).

• Incubation conditions: Extend primary antibody incubation to overnight at 4°C to enhance sensitivity.

• Detection system: Switch to a more sensitive detection system (polymer-based or tyramide signal amplification).

Biological factors:

• Developmental stage: KRT40 expression is differentiation-dependent; verify developmental stage of hair follicles in your samples.

• Hair cycle phase: Expression varies with hair cycle phase; anagen follicles show strongest expression.

• Species differences: KRT40 expression patterns vary between species; confirm antibody species reactivity .

• Sample quality: Hair follicle degradation can occur rapidly; minimize time between collection and fixation.

Validation approaches:

This systematic approach has resolved immunostaining issues in multiple published studies examining hair follicle biology and pathology.

What is the optimal protocol for KRT40 detection using Western blotting?

The following optimized Western blot protocol has been developed specifically for KRT40 detection:

Sample preparation:

• Harvest cells or tissue in RIPA buffer (150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris pH 8.0) with protease inhibitors

• For hair follicle samples, mechanical homogenization followed by sonication improves extraction

• Centrifuge at 14,000 × g for 15 minutes at 4°C and collect supernatant

• Determine protein concentration using BCA assay

Gel electrophoresis and transfer:

• Load 25-50 μg protein per lane on 10% SDS-PAGE gel

• Run at 100V until dye front reaches bottom of gel

• Transfer to PVDF membrane at 100V for 90 minutes in cold transfer buffer

• Confirm transfer efficiency with Ponceau S staining

Immunodetection:

• Block in 5% non-fat milk in TBST for 1 hour at room temperature

• Incubate with primary anti-KRT40 antibody (1:1000-1:3000 dilution) overnight at 4°C

• Wash 3 × 10 minutes with TBST

• Incubate with HRP-conjugated secondary antibody (1:5000) for 1 hour at room temperature

• Wash 3 × 10 minutes with TBST

• Develop using enhanced chemiluminescence substrate

• Expected band size: 44-48 kDa

Critical controls:

• Positive control: Hair follicle extracts (preferably human)

• Negative control: Cell lines known to be negative for KRT40

• Loading control: β-actin or GAPDH for normalization

This protocol has been verified to produce specific detection of KRT40 with minimal background or cross-reactivity.

How do I select the appropriate KRT40 antibody for my specific research application?

Selecting the optimal KRT40 antibody requires systematic evaluation of several key parameters:

1. Application compatibility:

• For Western blot: Antibodies that recognize denatured epitopes

• For IHC/IF: Antibodies that recognize native epitopes in fixed tissues

• For ELISA: Antibodies with high affinity and specificity in solution

2. Antibody format:

• Monoclonal antibodies (e.g., AE13 clone) offer high specificity and reproducibility

• Polyclonal antibodies provide higher sensitivity but potential cross-reactivity

• Consider species of primary antibody to avoid cross-reactivity in multiplexing experiments

3. Epitope targeting:

• Middle region antibodies show higher specificity for KRT40

• N-terminal antibodies may cross-react with keratin family members

• C-terminal targeting enables differentiation from closely related keratins

4. Validation data:

• Review images from suppliers showing expected staining patterns

• Check for validation across multiple techniques (WB, IHC, IF)

• Assess number of citations and published validation data

5. Species reactivity:

• Confirm validated reactivity with your species of interest

• Check sequence homology between species for the targeted epitope

• Consider cross-reactivity potential with other keratins in your model system

Decision matrix for common research scenarios:

These selection guidelines are based on published research protocols and technical expertise in keratin biology.

What are the latest advances in KRT40 detection methods for single-cell analysis?

Recent technological advances have expanded the toolkit for KRT40 detection at the single-cell level:

Single-cell RNA sequencing (scRNA-seq):

• Provides transcriptional profiling of KRT40 expression in heterogeneous cell populations

• Enables identification of KRT40-expressing cell subpopulations within hair follicles and epidermis

• Can be correlated with other keratin family members to create "keratin signatures" for cell type identification

• Limitations include potential dissociation bias for keratin-rich cells

Mass cytometry (CyTOF):

• Metal-tagged antibodies against KRT40 allow multiplexed detection with >40 markers

• Overcomes fluorescence spectral overlap limitations of conventional flow cytometry

• Enables deep phenotyping of KRT40+ cells and their associated markers

• Preserved epitope accessibility requires optimized permeabilization protocols

Imaging mass cytometry:

• Combines immunohistochemistry with mass spectrometry

• Allows visualization of KRT40 in spatial context with other markers

• Maintains tissue architecture while enabling high-parameter analysis

• Requires metal-conjugated KRT40 antibodies with validated specificity

Single-cell Western blotting:

• Microfluidic platforms now enable protein analysis at single-cell resolution

• Can detect KRT40 protein expression heterogeneity in sorted cell populations

• Provides absolute quantification of KRT40 at the single-cell level

• Currently limited by throughput compared to cytometry approaches

Methodological considerations:

• Cell isolation techniques must preserve keratin integrity (gentle dissociation)

• Fixation and permeabilization protocols require optimization for keratins

• Validation across multiple platforms ensures reliable results

• Computational analysis frameworks help interpret complex single-cell data

These emerging technologies are transforming our understanding of KRT40 biology by revealing previously undetectable expression patterns and cell-type associations at unprecedented resolution.

How can KRT40 antibodies be utilized in hair disorder research?

KRT40 antibodies have become valuable tools in investigating various hair disorders through multiple methodological approaches:

Research applications in hair pathology:

• Alopecia research: KRT40 antibodies can identify alterations in hair shaft keratin expression patterns in various forms of alopecia, revealing dysregulation of terminal differentiation.

• Hair shaft disorders: Abnormal KRT40 expression or localization has been observed in conditions like monilethrix and trichorrhexis nodosa, providing insights into pathological mechanisms.

• Scarring vs. non-scarring alopecia differentiation: Differential patterns of KRT40 immunostaining help distinguish between these two major categories of hair loss.

• Treatment response assessment: KRT40 immunostaining before and after treatment can serve as a biological marker for hair follicle recovery and normalization.

Methodological approach:

• Use standardized 4mm scalp punch biopsies

• Process tissues with consistent fixation protocols (10% neutral buffered formalin for 24h)

• Section both vertically and horizontally to capture different views of hair follicle structure

• Apply optimized immunostaining protocol for KRT40 detection

• Implement semi-quantitative scoring of KRT40 expression intensity and pattern

• Compare findings with established normal controls and disease standards

Quantitative evaluation methods:

• Digital image analysis with pixel intensity quantification

• Ratio of KRT40+ to total hair follicle area calculation

• Co-localization with other hair keratins (KRT35, KRT85)

This methodological framework has contributed to our understanding of pathological processes in multiple hair disorders and continues to inform diagnostic and therapeutic developments .

What controls are necessary for validating KRT40 antibody specificity in research applications?

Rigorous validation of KRT40 antibody specificity requires a comprehensive panel of controls:

Positive controls:

• Tissue-based: Human hair follicles in anagen phase (specifically cortex region)

• Cell line-based: Keratinocyte lines with confirmed KRT40 expression

• Recombinant protein: Purified KRT40 protein for Western blot positive control

• Overexpression system: Cells transfected with KRT40 expression construct

Negative controls:

• Primary antibody omission: Tissue processed identically but without primary antibody

• Isotype control: Non-specific antibody of same isotype and concentration

• Absorption control: Primary antibody pre-incubated with excess KRT40 antigen

• Biological negative: Tissues known to lack KRT40 expression (e.g., liver)

• Knockout/knockdown: When available, KRT40 knockout or siRNA knockdown samples

Specificity assessment methods:

• Multi-technique validation: Confirm consistent patterns across WB, IHC, and IF

• Epitope mapping: Test antibodies targeting different KRT40 regions

• Mass spectrometry validation: Confirm identity of immunoprecipitated protein

• Cross-reactivity testing: Evaluate against closely related keratins (especially KRT35)

Documentation standards:

• Record all control results with representative images

• Include detailed antibody information (clone, lot, dilution, incubation)

• Maintain consistency in imaging parameters between experimental and control samples

• Quantify signal-to-noise ratios in control experiments

This comprehensive validation approach ensures experimental robustness and reproducibility in KRT40 research .

What are the current techniques for multiplex detection of KRT40 with other hair follicle markers?

Advanced multiplex detection techniques have revolutionized the study of KRT40 in relation to other hair follicle markers:

Fluorescence-based multiplex immunostaining:

• Sequential multi-epitope labeling: Utilizes primary antibodies from different species with species-specific secondary antibodies

  • Enables 4-5 marker detection on single tissue section

  • Requires careful optimization of antibody order and concentrations

  • Example panel: KRT40 (mouse mAb) + KRT75 (rabbit pAb) + CD200 (goat pAb) + Ki67 (rat mAb)

• Spectral unmixing approaches: Employs fluorophores with overlapping spectra and computational separation

  • Enables 6-8 marker detection simultaneously

  • Requires specialized imaging systems with spectral detectors

  • Reduces issues with antibody cross-reactivity between sequential rounds

• Tyramide signal amplification (TSA): Utilizes enzyme-mediated deposition of fluorescent tyramides

  • Enables use of same species antibodies through sequential stripping

  • Provides signal amplification for low-abundance targets

  • Requires precise protocol optimization for each antibody

Mass spectrometry-based multiplex approaches:

• Imaging mass cytometry: Uses metal-tagged antibodies detected by laser ablation and mass cytometry

  • Enables >40 marker detection without spectral overlap concerns

  • Preserves spatial information with subcellular resolution

  • Requires specialized equipment but eliminates autofluorescence issues

Protocol considerations for KRT40 multiplex detection:

• Optimize antigen retrieval conditions compatible with all target epitopes

• Test antibody combinations to ensure no steric hindrance between closely located epitopes

• Implement consistent blocking to minimize background across all channels

• Include single-stain controls for each marker to verify specificity in multiplex context

• Apply computational analysis for co-localization quantification

These multiplexing approaches have enabled comprehensive characterization of hair follicle biology, revealing complex relationships between KRT40 expression and other structural and signaling markers in normal and pathological conditions.

How do fixation conditions affect KRT40 antibody performance in immunohistochemistry?

Fixation parameters significantly impact KRT40 detection in immunohistochemical applications:

Effects of different fixatives:

Critical fixation parameters:

• Fixation duration: Prolonged fixation (>72h) significantly reduces KRT40 immunoreactivity through excessive cross-linking

• Temperature: Room temperature fixation balances penetration rate and epitope preservation

• Sample size: Tissues >5mm thick require longer fixation but risk overfixation of outer regions

• pH: Maintain fixative pH between 7.2-7.4 for optimal results

• Prefixation delay: Minimize time between sample collection and fixation (<30 minutes)

Optimized antigen retrieval by fixation method:

• Formalin-fixed: Heat-induced epitope retrieval with citrate buffer (pH 6.0) for 20 minutes

• Paraformaldehyde-fixed: Lower temperature (90°C) citrate retrieval for 15 minutes

• Zinc-fixed: Milder retrieval conditions or potentially no retrieval required

Practical recommendations:

• Standardize fixation protocols across experiments for consistent results

• Document fixation parameters in research publications

• Include fixation time series in antibody validation studies

• Consider dual fixation protocols (brief formaldehyde followed by alcohol) for challenging epitopes

These evidence-based recommendations derive from systematic studies of fixation effects on keratin epitope accessibility and have been validated in multiple research contexts .

What are the considerations for quantitative analysis of KRT40 expression in research samples?

Quantitative analysis of KRT40 expression requires careful attention to methodological details across different techniques:

Western blot quantification:

• Sample normalization: Total protein normalization using stain-free technology provides more reliable results than single housekeeping proteins

• Linear dynamic range: Establish assay linearity with dilution series of positive control samples

• Densitometry: Use integrated density values rather than peak intensity for more accurate quantification

• Statistical approach: Normalize to control samples and analyze using appropriate statistical tests for experimental design

• Technical replication: Minimum of three technical and biological replicates recommended

IHC/IF quantification approaches:

• H-score method: Combines intensity (0-3) and percentage of positive cells for semi-quantitative analysis

• Digital image analysis: Automated pixel intensity measurement with defined thresholds

• Comparison methods: Always include reference standards on same slide/batch

• Region selection: Analyze multiple randomly selected fields (minimum 5 per sample)

• Blinded assessment: Implement scorer blinding to experimental conditions

ELISA quantification considerations:

• Standard curve: Generate 7-point standard curve with concentration range of 0.156-10 ng/mL

• Sample dilution optimization: Test multiple dilutions to ensure readings fall within linear range

• Precision assessment: Intra-assay CV should be <8%, inter-assay CV <10%

• Spike recovery: Validate accuracy through spike recovery experiments (80-120% recovery)

• Reference ranges: Establish normal reference ranges for relevant sample types

Data presentation standards:

• Include representative blots/images alongside quantification

• Present raw data points in addition to means/medians

• Report normalization method and statistical approach

• Include positive and negative controls in data presentation

• Specify antibody details, lot number, and dilution

These quantification approaches provide rigorous, reproducible assessment of KRT40 expression and have been validated across multiple experimental contexts .